![](https://cttc.co/sites/default/files/article_images/Screen Shot 2018-07-05 at 9.41.55 AM.png)
Vanderbilt University has signed a licensing agreement with Nashville-based start-up Appello Pharmaceuticals, Inc. to advance novel compounds developed by researchers in the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) for the treatment of Parkinson’s disease.
- Read more about Vanderbilt licenses compound to Nashville’s Appello to advance Parkinson’s therapies